Background and purpose: Toll-like receptors (TLRs) are involved in innate immunity and inflammatory responses in various diseases. Our study aimed to investigate the association between the levels of soluble TLR4 (sTLR4) and soluble TLR2 (sTLR2) and clinical outcomes following intracerebral hemorrhage (ICH). Methods: Patients admitted to department of Neurology with acute ICH were included. Plasma levels of sTLR4 and sTLR2 after ICH were measured by enzyme-linked immunosorbent assay. Poor clinical outcome was defined as a modified Rankin score (mRS) of 3-6 at 3-month and 12-month after onset. Results: All 207 patients with ICH and 100 non-stroke controls were included in our analysis. The mean sTLR4 level was 4.53+1.51 +1.51 ng/ml and mean sTLR2 level was 3.65+0.72 +0.72 ng/ml. There was significant trend towards worse clinical outcomes with increasing sTLR4 and sTLR2 terciles at 3 and 12 months. According to receiver operating curve (ROC), the sTLR4 was reliable predictor for poor clinical outcome at 3 months (ROC=0.75) =0.75) and 12 months (ROC=0.74). =0.74). The sTLR2 was less reliable predictor for poor clinical outcome at 3 months (ROC=0.64) =0.64) and 12 months (ROC=0.65). =0.65). The level of sTLR4 was an independent predictor of poor clinical outcome at 12- month (OR 1.24, 95 % CI 1.16-1.80; P =0.019). Conclusions: The sTLR4 quantification may provide accurate prognostic information after ICH.